No-Cost, No-Obligation
Talcum Powder
Ovarian Cancer
Lawsuit Case Review

Talcum Powder Cancer Lawsuit Center

Who Can File a Talcum Powder Ovarian Cancer Lawsuit?


Talcum Powder Ovarian Cancer Lawsuit News

Review Of International Journal Of Cancer Talcum Study

An International Journal of Cancer article discovered that talcum powder may increase the risk of ovarian cancer up to 10 percent.

Monday, November 30, 2015 - A 1999 study conducted by the International Journal of Cancer looked into the possible connections between talcum powder and an increased risk in the contraction of ovarian cancer. The study conducted a population-based, case-control study that looked into patterns of association between talcum powder and ovarian cancer that are at the heart of hundreds of lawsuits currently filed against Johnson & Johnson alleging the company should have been aware of the cancerous risk of their talcum powder products.

The 1999 study was published in the November issue of the International Journal of Cancer and delved into the various studies that had been performed in the scientific community looking at the link between talcum powder and ovarian cancer. The first of these studies was conducted in 1971 and did discover a link between the two. Between that time and when the International Journal of Cancer study was published, a good deal of talcum powder research was performed with results coming in on both sides of the debate.

The International Journal of Cancer study did not in itself confirm that talc is connected directly to ovarian cancer, but it did point out some connections that have been made in other studies. It was noted in the results of the study that regular use of talcum powder genitally for women made it possible for talc particles to travel up the uterine tract and become lodged in the uterus. This has been pointed out in numerous studies as the function by which talcum powder can cause ovarian cancer in women.

The study also points out that although talc and ovarian cancer did not elicit a certain cause and effect relationship, there was a consistent association found between the two that was judged to be significant beyond factors such as recall of confounding biases. The relationship was characterized as weak, but did exist and gave the scientists enough evidence to make the determination that talc has a possibility to be linked to an increased risk in the contraction of ovarian cancer. The study found that avoiding the regular use of talcum power genitally for women may reduce the risk of ovarian cancer by up to 10 percent.

Hundreds of lawsuits around the country have been filed against Johnson & Johnson claiming that the company was negligent in not warning their customers of the possible associated between talcum powder and ovarian cancer, and that the company may have even known of this relationship and intentionally determined not to tell consumers in the interest of protecting profits. Plaintiffs claim that the ovarian cancer they contracted was linked to the talcum powder they used, and Johnson & Johnson's failure to apply a warning label to their product detailing this risk should result in the company paying damages for the physical and emotional pain they have caused their customers.

Hundreds of lawsuits against Johnson & Johnson have been filed nationwide, with more than 100 based in St. Louis and the state of New Jersey alone. Multicounty litigation is a likely outcome for the lawsuits in New Jersey, as a motion to transfer has already been supported by both the defendants and plaintiffs in those cases.

Information provided by, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.